AGT and COVID-19: COVID-19 patients show a broad spectrum of endothelial alterations, such as an increase in the activity of coagulation factor VIII and a high increase in von Willebrand factor [67] and angiotensin II level in the plasma, associated with viral load and lung damage [68].